Chloe Khoo

513 total citations
9 papers, 132 citations indexed

About

Chloe Khoo is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chloe Khoo has authored 9 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Chloe Khoo's work include Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (3 papers) and CAR-T cell therapy research (2 papers). Chloe Khoo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (3 papers) and CAR-T cell therapy research (2 papers). Chloe Khoo collaborates with scholars based in Australia, United States and Italy. Chloe Khoo's co-authors include Shahneen Sandhu, Serigne Lo, Peter K. H. Lau, Donna Milne, Michael Jefford, Jeanette Raleigh, Kortnye Smith, Julia Lai‐Kwon, Karolina Lisy and Christina Guo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Chloe Khoo

9 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloe Khoo Australia	6	93	32	23	18	11	9	132
René L. Roux United Kingdom	8	55 0.6×	21 0.7×	25 1.1×	42 2.3×	6 0.5×	18	162
Omotayo Fasan United States	6	55 0.6×	6 0.2×	17 0.7×	17 0.9×	12 1.1×	15	112
Helen Higgins United Kingdom	6	64 0.7×	15 0.5×	17 0.7×	9 0.5×	3 0.3×	19	112
María R. Alonso Spain	5	75 0.8×	17 0.5×	46 2.0×	27 1.5×	8 0.7×	5	138
Yohei Hamanaka Japan	9	72 0.8×	23 0.7×	40 1.7×	26 1.4×	16 1.5×	25	165
Esther Hwang United States	5	27 0.3×	24 0.8×	22 1.0×	12 0.7×	4 0.4×	14	108
Marcin Ostrowski Poland	7	34 0.4×	74 2.3×	20 0.9×	10 0.6×	4 0.4×	14	121
Hrisheekesh J Vaidya United Kingdom	4	57 0.6×	17 0.5×	13 0.6×	4 0.2×	15 1.4×	6	155
Jonathan Ashley Jefferson United States	5	45 0.5×	10 0.3×	29 1.3×	8 0.4×	19 1.7×	6	141
Rebecca Hoyd United States	8	114 1.2×	43 1.3×	54 2.3×	3 0.2×	24 2.2×	28	184

Countries citing papers authored by Chloe Khoo

Since Specialization

Citations

This map shows the geographic impact of Chloe Khoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Khoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Khoo more than expected).

Fields of papers citing papers by Chloe Khoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Khoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Khoo. The network helps show where Chloe Khoo may publish in the future.

Co-authorship network of co-authors of Chloe Khoo

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Khoo. A scholar is included among the top collaborators of Chloe Khoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Khoo. Chloe Khoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Dearden, Helen Clare, Lewis Au, Daniel Wang, et al.. (2021). Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy. European Journal of Cancer. 153. 168–178. 24 indexed citations

2.

Smibert, Olivia, Christina Guo, Chloe Khoo, et al.. (2019). Microbiome transplantation and modulation of immune related adverse events. EClinicalMedicine. 8. 10–11. 5 indexed citations

3.

Lai‐Kwon, Julia, Chloe Khoo, Serigne Lo, et al.. (2019). The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors. Journal of Cancer Survivorship. 13(4). 503–511. 36 indexed citations

4.

Guo, Christina, Marliese Alexander, Peter K. H. Lau, et al.. (2019). A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies. European Journal of Cancer. 124. 15–24. 35 indexed citations

5.

Khoo, Chloe, et al.. (2019). Pneumocystis jirovecii in a patient on dose‐dense chemotherapy for early breast cancer. Respirology Case Reports. 7(7). e00459–e00459. 7 indexed citations

6.

Lasocki, Arian, Chloe Khoo, Peter K. H. Lau, David L. Kok, & Grant A. McArthur. (2019). High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges. Neuro-Oncology. 22(3). 423–432. 10 indexed citations

7.

Dearden, Helen Clare, Lewis Au, Lisa Zimmer, et al.. (2018). Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy.. Journal of Clinical Oncology. 36(15_suppl). 9545–9545. 2 indexed citations

8.

Goldinger, Simone M., Serigne Lo, Jessica C. Hassel, et al.. (2018). The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series.. Journal of Clinical Oncology. 36(15_suppl). e21588–e21588. 11 indexed citations

9.

Man, Johnathan, Chloe Khoo, Bo Gao, et al.. (2016). Lymph node dissection in early epithelial ovarian cancer (EOC) – Results from a population based study. Annals of Oncology. 27. vi300–vi300. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact